SCHEMBL6502923

SCHEMBL6502923

COC(=O)CNC(=O)c1ccccc1OCC(O)CN1CCC(Oc2ccc(Cl)cc2)C1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.52
HRH1 P35367 2/20 0.46
CCR3 P51677 2/20 0.46
CCR1 P32246 2/20 0.46
DRD4 P21917 5/20 0.45
DRD2 P14416 4/20 0.45
DRD3 P35462 3/20 0.45
SCN1A P35498 1/20 0.45
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
ABCB1 P08183 4/20 0.44
HSD17B10 Q99714 1/20 0.43
ACACB O00763 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6210324 0.95 CYP2D6 (0.55) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6216008 0.93 ABCB1 (0.47) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6215764 0.92 CYP2D6 (0.51) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6212247 0.91 HRH1 (0.57) HRH1CCR3CCR1
SCHEMBL6211304 0.90 CCR3 (0.44) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6212693 0.90 HRH1 (0.51) CYP2D6HRH1CCR3DRD4DRD2
SCHEMBL6214289 0.87 DRD2 (0.52) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6212528 0.87 CYP2D6 (0.47) CYP2D6HRH1CCR3CCR1DRD4
SCHEMBL6214634 0.86 ABCB1 (0.59) HRH1CCR3CCR1DRD4DRD2
SCHEMBL6217490 0.85 CYP2D6 (0.53) CYP2D6CCR1DRD4SCN1ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951874-B2 Compounds ASTRAZENECA AB (SE) 2005-10-04 US disclosed
CN-1458281-A Coronary virus RNA interference preparation for severe acute respiratory syndrome pathogen HUANQIU ZHONGJIA BIOLOG SCIENC (CN) 2003-11-26 CN disclosed
CN-1426412-A Novel compounds ASTRAZENECA AB (SE) 2003-06-25 CN disclosed